Healthcare -
Biotechnology - NASDAQ - US
$ 3.34
2.77 %
$ 213 M
Market Cap
-2.9
P/E
LRMR - CASH FROM OPERATIONS
Cash from Operations LRMR - Larimar Therapeutics, Inc.
-33.5 M
LAST VALUE
10.86%
2 YEAR CAGR
8.26%
5 YEAR CAGR
-8.35%
10 YEAR CAGR